Alpha Teknova, Inc. (TKNO)
3.03
+0.24
(+8.60%)
USD |
NASDAQ |
Mar 16, 16:00
3.04
+0.01
(+0.33%)
After-Hours: 20:00
Alpha Teknova EPS Diluted (Quarterly) : -0.0889 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cytokinetics, Inc. | -1.495 |
| Spero Therapeutics, Inc. | -0.1312 |
| Pyxis Oncology, Inc. | -0.3517 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.758M |
| Revenue (Quarterly) | 9.984M |
| Total Expenses (Quarterly) | 14.74M |
| Enterprise Value | 156.44M |
| Gross Profit Margin (Quarterly) | 29.62% |
| Profit Margin (Quarterly) | -47.66% |
| Earnings Yield | -10.65% |
| Normalized Earnings Yield | -10.44 |